Research
The Coalition for Epidemic Preparedness Innovations (CEPI) launched a new survey this week to assess the vaccine manufacturing capacity and capabilities of Africa, Southeast Asia, the Middle East, and Latin America, to better inform ahead of future epidemics.
“While incredible efforts were... Read More »
Up to $4.1 million in non-dilutive funding from nonprofit CARB-X was announced this week for Summit Therapeutics to help develop a first-in-class antibiotic to treat multidrug-resistant infections, and specifically, carbapenem-resistant Enterobacteriaceae (CRE) infections.
This funding will aid... Read More »
A Regeneron Pharmaceuticals, Inc.-created drug cocktail of casirivimab with imdevimab, REGEN-COV, was recently shown to provide a 70 percent reduced risk of hospitalization or death and shortened symptom duration in non-hospitalized patients afflicted with COVID-19.
The drug cocktail is meant... Read More »
Across all adult age groups, going as high as 95 years old, a phase two trial of the Sanofi and GSK adjuvanted recombinant COVID-19 vaccine candidate has demonstrated high antibody responses and no safety concerns, according to interim data released this week.
Strong immune responses included a... Read More »
The results of a real-world Centers for Disease Control and Prevention (CDC) study of 1,843 health workers across the United States showed last week that COVID-19 mRNA vaccines authorized by the U.S. Food and Drug Administration (FDA) are 94 percent effective.
Currently approved mRNA vaccines... Read More »
Fearing for equitable access to COVID-19 vaccines, COVAX has set up a manufacturing task force to coordinate with other organizations in identifying and tackling roadblocks to those critical health supplies.
According to the task force, the production output of COVID-19 vaccines is set to... Read More »
In a public statement released last week, nine national organizations highlighted the pains COVID-19 inflicted upon the world in general and already historically marginalized populations in specific and pressed for strategies to improve crisis standards of care, along with equity.
“The... Read More »
A new low-cost, rapid diagnostic test for COVID-19 developed by Penn Medicine provides results within four minutes and is 90 percent accurate.
According to a paper published this week in Matter, the test – RAPID 1.0 (Real-time Accurate Portable Impedimetric Detection prototype 1.0) – is... Read More »
Biotechnology company INOVIO revealed that the placebo-controlled and blinded phase two segment of a United States clinical vaccine trial has shown positive, safe, and well-tolerated results for INO-4800 when used against COVID-19.
As a result of the test results, a 2 mg dose will be used for... Read More »
America’s historically underfunded public health system played a major role in the nation’s laggard COVID-19 response, according to a new report released by the Trust for America’s Health (TFAH).
And while it’s too soon to calculate with precision, it is likely that the United States... Read More »
The National Institute of Allergy and Infectious Diseases announced Friday it has awarded researchers at the University of Texas Medica Branch (UTMB) at Galveston $11.3 million to study Ebola.
The multiyear grant will fund research into the immunopathogenesis of Ebola, specifically why cells... Read More »
The Biomedical Advanced Research and Development Authority (BARDA) has exercised the final $12 million option to produce the remaining $202 million smallpox vaccine order.
The order would be supplied by JYNNEOS, encompassing the Smallpox and Monkeypox vaccine. The option covers the supply of... Read More »
The Coalition for Epidemic Preparedness Innovations (CEPI) and Dynavax Technologies Corporation expanded the terms of a manufacturing agreement last week to include an additional $77 million for adjuvant used in COVID-19 vaccines.
The funding injection, provided in the form of a forgivable loan... Read More »
A new report by the General Accountability Office (GAO) found that most of the U.S. nuclear triad is nearing or past their planned end-of-life dates and that the Departments of Defense and Energy must plan their replacements carefully.
The report found that most of the nuclear triad, three... Read More »
U.S. Sen. Jeff Merkley (D-OR) joined other members of Congress to call on Pfizer, Moderna, and Johnson & Johnson to expand access to the COVID-19 vaccine globally.
In a letter sent on May 5, Merkley, along with Sens. Elizabeth Warren (D-MA), Edward J. Markey (D-MA), Tammy Baldwin (D-WI), and... Read More »
The commercial-stage pharmaceutical company SIGA Technologies, Inc. has filed a New Drug Application (NDA) with the Food and Drug Administration (FDA) for the intravenous formulation (IV) of TPOXX.
The proposed NDA to treat human smallpox disease in adults and pediatric patients is the same as... Read More »
In an initial primary analysis of the Phase 2b trial of COVID-19 vaccine NVX-CoV-2373, a New England Journal of Medicine-published report revealed that the vaccine provided approximately 55 percent efficacy to non-HIV patients when pitted against the South African variant, B.1.351.
The Novavax,... Read More »
Moderna, Inc. reported initial data this week showing that in phase two testing, its mRNA COVID-19 vaccine proved effective and well-tolerated as a booster or a single 50 µg dose on the previously vaccinated, against both the original SARS-CoV-2 strain and two variants of concern.
In all, three... Read More »
Three Biomedical Advanced Research and Development Authority (BARDA) scientists have been selected as finalists for the Service to America Medals during Public Service Recognition Week this year, the group announced Monday.
David Boucher, Ph.D.; Dan Wolfe, Ph.D.; and John Lee, Ph.D., who... Read More »
As part of a phase three trial of the Novavax, Inc. COVID-19 vaccine, NVX-CoV2373, up to 3,000 volunteers between 12 and 17 years old will be dosed at up to 75 sites across the United States to determine potential pediatric applications.
While the number of vaccines for adults has been growing,... Read More »
In a call backed by the Infectious Diseases Society of America (IDSA), a bipartisan collection of more than 60 United States representatives wrote to House appropriators last week, asking for increased federal resources to address the growing threat of antimicrobial resistant (AMR)... Read More »
A new report, the COVID CRIME INDEX 2021 REPORT, compiled by BAE Systems Applied Intelligence, found that cybercrime has experienced a massive uptick of 74 percent among banks and insurers alike since the COVID-19 pandemic began.
The data, which focused on financial institutions and their... Read More »
While the COVID-19 pandemic has illustrated the dangers of ill-prepared public health initiatives, a new case study-based report from the global Resolve to Save Lives initiative and its president and CEO Dr. Tom Frieden highlights the numerous ways that governments can invest in and prioritize... Read More »
An Iowa State University research team is developing a new sensor capable of detecting Ebola in a single drop of blood while providing results in an hour.
Researchers indicated the sensor is based on DNA aptamers, described as short, single-stranded DNA molecules selectively bound to a specific... Read More »
The Biomedical Advanced Research and Development Authority (BARDA) and Enalare Therapeutics partnered this week to reformulate the agnostic respiratory stimulant ENA-001 into an intramuscular, emergency treatment for opioid-induced respiratory depression (OIRD).
The action is being undertaken... Read More »
On Friday, the Department of Homeland Security (DHS) Science and Technology (S&T) Directorate Center of Excellence’s (COE) Borders, Trade, and Immigration Institute (BTI) announced the release of a report on cross-border e-commerce.
Working with the University of Houston, the report looked at... Read More »
Los Alamos National Laboratory (LANL) researchers are espousing the benefits of a device capable of detecting biothreats from samples such as blood, water, CSF, food, and animal samples.
The Portable EnGineered Analytic Sensor with aUtomated Sampling (PEGASUS) is a miniaturized waveguide-based... Read More »
U.S. Sens. Elizabeth Warren (D-MA) and Marco Rubio (R-FL) reintroduced last week the U.S. Pharmaceutical Supply Chain Review Act to demand a study of the nation’s reliance on foreign nations for the pharmaceutical supply chain.
The bill would require a study produced by the Federal Trade... Read More »
Hundreds of non-hospitalized volunteers are being enrolled in a Phase 2/3 National Institutes of Health (NIH)-run trial of the SAB Biotherapeutics, Inc. creation SAB-185, a polyclonal antibody therapeutic meant to counter COVID-19.
The trial is known as ACTIV-2, part of the Accelerating COVID-19... Read More »
Researchers at the U.S. Department of Homeland Security (DHS) Science and Technology Directorate’s National Biodefense Analysis and Countermeasures Center (NBACC) have successfully designed and conducted a study to optimize methods for collecting and measure small amounts of the Ebola virus in... Read More »
Los Alamos National Laboratory researchers are espousing the benefits of a new artificial intelligence (AI) tool capable of identifying COVID-19-related conspiracy theories on social media.
The AI models how the conspiracy theories evolved and how they could someday help public health officials... Read More »
The Defense Advanced Research Projects Agency (DARPA) recently awarded contracts to FLIR Systems, Leidos, and Charles River Analytics to create lightweight materials and more adaptable countermeasures for equipment protective against chemical and biological threats.
The problem is, while... Read More »
Several over-the-counter drugs could potentially find new lives treating COVID-19 symptoms, as the National Institutes of Health (NIH) announced this week that $155 million would be invested into a phase three trial of up to seven self-administered medications to that end.
It will be a... Read More »
The U.S. Food and Drug Administration (FDA) revoked last week the emergency use authorization (EUA) for the sole use of the monoclonal antibody therapy bamlanivimab against COVID-19.
“Based on its ongoing analysis of emerging scientific data, specifically the sustained increase of SARS-CoV-2... Read More »
A new report by the World Health Organization (WHO) shows that there remains a relative dearth of antibacterial treatments in the pipeline, despite the growing threat of antibiotic resistance.
The WHOʻs annual Antibacterial Pipeline Report found that of the 43 antibiotics that are currently in... Read More »
